Tirilazad

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tirilazad is a drug proposed to treat acute ischaemic stroke, however results are mixed as to whether the drug truly treats stroke.^[1]

Mixed results

When tested on animal models, tirilazad protects brain tissue, and reduces any brain damage. On the contrary, the drug fails to treat, and even worsens a stroke when studied on a human being.

Usage in treatment of stroke

Tirilazad currently has no usage in the clinical treatment of stroke.

References

↑ “Tirilazad for acute ischaemic stroke”. Retrieved 2007-07-28.

[1] “Tirilazad for acute ischaemic stroke”. Retrieved 2007-07-28.

[1]